Clinical Trial Detail

NCT ID NCT03047473
Title Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme (SEJ)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Clinique Neuro-Outaouais
Indications

glioblastoma multiforme

Therapies

Avelumab

Age Groups: senior adult

No variant requirements are available.